Wellington Management Group’s Five Prime Therapeutics, Inc. FPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-761,447
| Closed | -$28.7M | – | 2379 |
|
|
2021
Q1 | $28.7M | Sell |
761,447
-679,514
| -47% | -$16.9M | 0.01% | 977 |
|
|
2020
Q4 | $24.5M | Buy |
1,440,961
+155,615
| +12% | +$1.95M | ﹤0.01% | 990 |
|
|
2020
Q3 | $6.04M | Buy |
1,285,346
+2,823
| +0.2% | +$14.3K | ﹤0.01% | 1227 |
|
|
2020
Q2 | $7.82M | Buy |
1,282,523
+41,503
| +3% | +$171K | ﹤0.01% | 1121 |
|
|
2020
Q1 | $2.82M | Sell |
1,241,020
-11,758
| -0.9% | -$49.9K | ﹤0.01% | 1306 |
|
|
2019
Q4 | $5.75M | Sell |
1,252,778
-1,167,151
| -48% | -$4.62M | ﹤0.01% | 1300 |
|
|
2019
Q3 | $9.38M | Sell |
2,419,929
-489,890
| -17% | -$2.69M | ﹤0.01% | 1184 |
|
|
2019
Q2 | $17.5M | Sell |
2,909,819
-1,064,089
| -27% | -$10.2M | ﹤0.01% | 1044 |
|
|
2019
Q1 | $53.3M | Sell |
3,973,908
-46,916
| -1% | -$535K | 0.01% | 717 |
|
|
2018
Q4 | $37.4M | Sell |
4,020,824
-489,913
| -11% | -$5.83M | 0.01% | 802 |
|
|
2018
Q3 | $62.8M | Buy |
4,510,737
+190,767
| +4% | +$2.84M | 0.01% | 732 |
|
|
2018
Q2 | $68.3M | Sell |
4,319,970
-219,376
| -5% | -$3.83M | 0.02% | 697 |
|
|
2018
Q1 | $78M | Buy |
4,539,346
+1,559,764
| +52% | +$30.4M | 0.02% | 653 |
|
|
2017
Q4 | $65.3M | Buy |
2,979,582
+83,036
| +3% | +$2.67M | 0.01% | 690 |
|
|
2017
Q3 | $118M | Sell |
2,896,546
-26,594
| -0.9% | -$835K | 0.03% | 497 |
|
|
2017
Q2 | $88M | Buy |
2,923,140
+704,899
| +32% | +$22M | 0.02% | 557 |
|
|
2017
Q1 | $80.2M | Sell |
2,218,241
-173,631
| -7% | -$7.65M | 0.02% | 577 |
|
|
2016
Q4 | $120M | Sell |
2,391,872
-105,114
| -4% | -$5.52M | 0.03% | 434 |
|
|
2016
Q3 | $131M | Sell |
2,496,986
-322,358
| -11% | -$15.4M | 0.03% | 409 |
|
|
2016
Q2 | $117M | Sell |
2,819,344
-120,268
| -4% | -$5.23M | 0.03% | 433 |
|
|
2016
Q1 | $119M | Sell |
2,939,612
-365,942
| -11% | -$12.6M | 0.03% | 423 |
|
|
2015
Q4 | $137M | Sell |
3,305,554
-305,229
| -8% | -$10.2M | 0.04% | 389 |
|
|
2015
Q3 | $55.6M | Buy |
3,610,783
+649,712
| +22% | +$14M | 0.02% | 646 |
|
|
2015
Q2 | $73.6M | Sell |
2,961,071
-315,451
| -10% | -$7.03M | 0.02% | 593 |
|
|
2015
Q1 | $74.9M | Buy |
3,276,522
+985,523
| +43% | +$24.9M | 0.02% | 607 |
|
|
2014
Q4 | $61.9M | Buy |
2,290,999
+143,894
| +7% | +$2.48M | 0.02% | 663 |
|
|
2014
Q3 | $25.2M | Buy |
2,147,105
+242,434
| +13% | +$3.06M | 0.01% | 938 |
|
|
2014
Q2 | $29.6M | Buy |
1,904,671
+43,708
| +2% | +$627K | 0.01% | 904 |
|
|
2014
Q1 | $36.6M | Buy |
1,860,963
+936,001
| +101% | +$15.9M | 0.01% | 840 |
|
|
2013
Q4 | $15.5M | Buy |
+924,962
| New | +$11.5M | ﹤0.01% | 1097 |
|
Wellington Management Group's FPRX Position: Q2 2021 in Review
Wellington Management Group sold out of Five Prime Therapeutics, Inc. (FPRX) in Q2 2021, closing a stake of 761,447 shares — an estimated $28.7M sold.
Wellington Management Group first reported a position in FPRX in Q4 2013 and held it in 30 quarters. The position peaked at $137M in Q4 2015. 0 funds tracked by Wall St. Rank hold FPRX as of Q2 2021.
- Wellington Management Group reported no remaining Five Prime Therapeutics, Inc. position as of Q2 2021 after selling out during the quarter.
- Wellington Management Group sold 761,447 Five Prime Therapeutics, Inc. shares in Q2 2021, an estimated $28.7M.
- Wellington Management Group first reported a position in Five Prime Therapeutics, Inc. in Q4 2013 and held it in 30 quarters.
- Wellington Management Group's Five Prime Therapeutics, Inc. position peaked at $137M in Q4 2015.
- 0 funds tracked by Wall St. Rank held Five Prime Therapeutics, Inc. as of Q2 2021.
Based on Wellington Management Group's 13F filing for Q2 2021, filed 16 Aug 2021.